Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.20
HRC's Cash to Debt is ranked higher than
50% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.04 vs. HRC: 0.20 )
HRC' s 10-Year Cash to Debt Range
Min: 0.13   Max: 2.32
Current: 0.2

0.13
2.32
Equity to Asset 0.43
HRC's Equity to Asset is ranked higher than
57% of the 303 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.57 vs. HRC: 0.43 )
HRC' s 10-Year Equity to Asset Range
Min: 0.17   Max: 0.67
Current: 0.43

0.17
0.67
Interest Coverage 12.51
HRC's Interest Coverage is ranked higher than
61% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.08 vs. HRC: 12.51 )
HRC' s 10-Year Interest Coverage Range
Min: 5.45   Max: 25.97
Current: 12.51

5.45
25.97
F-Score: 6
Z-Score: 4.46
M-Score: -2.86
WACC vs ROIC
13.59%
5.74%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.86
HRC's Operating margin (%) is ranked higher than
74% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.43 vs. HRC: 6.86 )
HRC' s 10-Year Operating margin (%) Range
Min: -27.59   Max: 19.59
Current: 6.86

-27.59
19.59
Net-margin (%) 3.39
HRC's Net-margin (%) is ranked higher than
71% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.28 vs. HRC: 3.39 )
HRC' s 10-Year Net-margin (%) Range
Min: -29.2   Max: 17.17
Current: 3.39

-29.2
17.17
ROE (%) 7.40
HRC's ROE (%) is ranked higher than
75% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.57 vs. HRC: 7.40 )
HRC' s 10-Year ROE (%) Range
Min: -47.88   Max: 21.05
Current: 7.4

-47.88
21.05
ROA (%) 3.71
HRC's ROA (%) is ranked higher than
74% of the 313 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.93 vs. HRC: 3.71 )
HRC' s 10-Year ROA (%) Range
Min: -27.72   Max: 10.58
Current: 3.71

-27.72
10.58
ROC (Joel Greenblatt) (%) 21.05
HRC's ROC (Joel Greenblatt) (%) is ranked higher than
79% of the 312 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.46 vs. HRC: 21.05 )
HRC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -69.35   Max: 89.22
Current: 21.05

-69.35
89.22
Revenue Growth (3Y)(%) 5.00
HRC's Revenue Growth (3Y)(%) is ranked higher than
73% of the 264 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. HRC: 5.00 )
HRC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -9.2   Max: 8.9
Current: 5

-9.2
8.9
EBITDA Growth (3Y)(%) -2.50
HRC's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. HRC: -2.50 )
HRC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -63.4   Max: 134.9
Current: -2.5

-63.4
134.9
EPS Growth (3Y)(%) -20.80
HRC's EPS Growth (3Y)(%) is ranked higher than
56% of the 229 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. HRC: -20.80 )
HRC' s 10-Year EPS Growth (3Y)(%) Range
Min: -27.8   Max: 28.9
Current: -20.8

-27.8
28.9
» HRC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

HRC Guru Trades in Q1 2014

David Dreman 207,145 sh (+3.12%)
John Keeley 1,514,809 sh (+0.64%)
Chuck Royce 524,270 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Ken Fisher 1,755,284 sh (-3.52%)
Paul Tudor Jones 10,500 sh (-29.53%)
Joel Greenblatt 161,218 sh (-52.23%)
» More
Q2 2014

HRC Guru Trades in Q2 2014

Paul Tudor Jones 14,000 sh (+33.33%)
David Dreman 228,119 sh (+10.13%)
Chuck Royce 521,470 sh (-0.53%)
Ken Fisher 1,706,884 sh (-2.76%)
Joel Greenblatt 90,281 sh (-44.00%)
John Keeley 481,948 sh (-68.18%)
» More
Q3 2014

HRC Guru Trades in Q3 2014

Jim Simons 7,400 sh (New)
Paul Tudor Jones 19,158 sh (+36.84%)
Chuck Royce 531,370 sh (+1.90%)
David Dreman 231,055 sh (+1.29%)
Ken Fisher 1,698,707 sh (-0.48%)
Joel Greenblatt 77,804 sh (-13.82%)
John Keeley 314,038 sh (-34.84%)
» More
Q4 2014

HRC Guru Trades in Q4 2014

Steven Cohen 825,600 sh (New)
Jim Simons 443,000 sh (+5886.49%)
Paul Tudor Jones 379,100 sh (+1878.81%)
David Dreman 241,924 sh (+4.70%)
Chuck Royce 534,570 sh (+0.60%)
John Keeley Sold Out
Ken Fisher 1,677,872 sh (-1.23%)
Joel Greenblatt 10,404 sh (-86.63%)
» More
» Details

Insider Trades

Latest Guru Trades with HRC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 50.70
HRC's P/E(ttm) is ranked higher than
73% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.70 vs. HRC: 50.70 )
HRC' s 10-Year P/E(ttm) Range
Min: 7.13   Max: 50.8
Current: 50.7

7.13
50.8
Forward P/E 19.46
HRC's Forward P/E is ranked higher than
88% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 163.93 vs. HRC: 19.46 )
N/A
PE(NRI) 50.40
HRC's PE(NRI) is ranked higher than
76% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 56.30 vs. HRC: 50.40 )
HRC' s 10-Year PE(NRI) Range
Min: 8.58   Max: 53.13
Current: 50.4

8.58
53.13
P/B 3.90
HRC's P/B is ranked higher than
61% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. HRC: 3.90 )
HRC' s 10-Year P/B Range
Min: 0.58   Max: 3.97
Current: 3.9

0.58
3.97
P/S 1.70
HRC's P/S is ranked higher than
80% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.10 vs. HRC: 1.70 )
HRC' s 10-Year P/S Range
Min: 0.4   Max: 1.95
Current: 1.7

0.4
1.95
PFCF 27.70
HRC's PFCF is ranked higher than
84% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 105.70 vs. HRC: 27.70 )
HRC' s 10-Year PFCF Range
Min: 5.78   Max: 192.44
Current: 27.7

5.78
192.44
POCF 15.02
HRC's POCF is ranked higher than
87% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.17 vs. HRC: 15.02 )
HRC' s 10-Year POCF Range
Min: 3.32   Max: 69.21
Current: 15.02

3.32
69.21
EV-to-EBIT 27.97
HRC's EV-to-EBIT is ranked higher than
79% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 36.81 vs. HRC: 27.97 )
HRC' s 10-Year EV-to-EBIT Range
Min: -19.8   Max: 28.7
Current: 27.97

-19.8
28.7
Shiller P/E 168.00
HRC's Shiller P/E is ranked higher than
72% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. HRC: 168.00 )
HRC' s 10-Year Shiller P/E Range
Min: 4.44   Max: 205.83
Current: 168

4.44
205.83
Current Ratio 1.89
HRC's Current Ratio is ranked higher than
63% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.62 vs. HRC: 1.89 )
HRC' s 10-Year Current Ratio Range
Min: 1.33   Max: 3.1
Current: 1.89

1.33
3.1
Quick Ratio 1.46
HRC's Quick Ratio is ranked higher than
67% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.77 vs. HRC: 1.46 )
HRC' s 10-Year Quick Ratio Range
Min: 1.15   Max: 2.72
Current: 1.46

1.15
2.72
Days Inventory 54.30
HRC's Days Inventory is ranked higher than
94% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 135.02 vs. HRC: 54.30 )
HRC' s 10-Year Days Inventory Range
Min: 31.31   Max: 68.91
Current: 54.3

31.31
68.91
Days Sales Outstanding 77.85
HRC's Days Sales Outstanding is ranked higher than
68% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 70.75 vs. HRC: 77.85 )
HRC' s 10-Year Days Sales Outstanding Range
Min: 62.21   Max: 140.27
Current: 77.85

62.21
140.27

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.20
HRC's Dividend Yield is ranked higher than
50% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.27 vs. HRC: 1.20 )
HRC' s 10-Year Dividend Yield Range
Min: 0.89   Max: 6.05
Current: 1.2

0.89
6.05
Dividend Payout 0.60
HRC's Dividend Payout is ranked higher than
80% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. HRC: 0.60 )
HRC' s 10-Year Dividend Payout Range
Min: 0.11   Max: 5.65
Current: 0.6

0.11
5.65
Dividend growth (3y) 11.40
HRC's Dividend growth (3y) is ranked higher than
81% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. HRC: 11.40 )
HRC' s 10-Year Dividend growth (3y) Range
Min: -28.8   Max: 11.4
Current: 11.4

-28.8
11.4
Yield on cost (5-Year) 1.77
HRC's Yield on cost (5-Year) is ranked higher than
58% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.57 vs. HRC: 1.77 )
HRC' s 10-Year Yield on cost (5-Year) Range
Min: 1.31   Max: 8.93
Current: 1.77

1.31
8.93
Share Buyback Rate 2.90
HRC's Share Buyback Rate is ranked higher than
96% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.00 vs. HRC: 2.90 )
HRC' s 10-Year Share Buyback Rate Range
Min: 3   Max: -0.9
Current: 2.9

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 29.70
HRC's Price/Tangible Book is ranked higher than
51% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.70 vs. HRC: 29.70 )
HRC' s 10-Year Price/Tangible Book Range
Min: 1.47   Max: 26.07
Current: 29.7

1.47
26.07
Price/DCF (Projected) 1.70
HRC's Price/DCF (Projected) is ranked higher than
86% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.60 vs. HRC: 1.70 )
HRC' s 10-Year Price/DCF (Projected) Range
Min: 0.37   Max: 9.08
Current: 1.7

0.37
9.08
Price/Median PS Value 1.40
HRC's Price/Median PS Value is ranked higher than
69% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. HRC: 1.40 )
HRC' s 10-Year Price/Median PS Value Range
Min: 0.35   Max: 1.58
Current: 1.4

0.35
1.58
Price/Graham Number 8.10
HRC's Price/Graham Number is ranked higher than
74% of the 342 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. HRC: 8.10 )
HRC' s 10-Year Price/Graham Number Range
Min: 0.65   Max: 7.08
Current: 8.1

0.65
7.08
Earnings Yield (Greenblatt) 3.60
HRC's Earnings Yield (Greenblatt) is ranked higher than
75% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. HRC: 3.60 )
HRC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.5   Max: 17.7
Current: 3.6

3.5
17.7
Forward Rate of Return (Yacktman) 2.97
HRC's Forward Rate of Return (Yacktman) is ranked higher than
67% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.65 vs. HRC: 2.97 )
HRC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -24.4   Max: 20.5
Current: 2.97

-24.4
20.5

Analyst Estimate

Sep15 Sep16
EPS($) 2.48 2.67
EPS without NRI($) 2.48 2.67

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:HB9.Germany,
Hill-Rom Holdings, Inc. was incorporated on August 7, 1969 in the State of Indiana. The Company is a manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions. The Company's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings worldwide, to enhance the safety and quality of patient care. The Company operates in three segments namely North America, Surgical and Respiratory Care and International. The North America segment sells and rents its patient support and near-patient technologies and services, as well as health information technology solutions in the U.S. and Canada. The Surgical and Respiratory Care segment sells and rents surgical and respiratory care products. The International segment sells and rents its products outside of the U.S. and Canada. The Company sells and rent its product to acute and extended care health care facilities through both direct sales force and distributors. It also sell products to patients in the home. Through its network of approximately 160 North American and 50 international service centers, and approximately 1,100 North American and 375 international service professionals. It competes on the basis of clinical expertise and resulting product clinical utility and ability to produce favorable outcomes, as well as value, quality, customer service, innovation and breadth and depth of product offerings. It competitors include: Stryker Corporation, SIZEWise Rentals, LLC, Universal Hospital Services, Inc., Rauland-Borg Corporation and among others. The Company owns a number of trademarks and service marks relating to its products and product services. The Company is subject to laws and regulations at both the federal and state levels.
» More Articles for HRC

Headlines

Articles On GuruFocus.com
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 21,029 Shares Dec 07 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 18,893 Shares Dec 03 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 20,005 Shares Nov 23 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 9,757 Shares Nov 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 33,670 Shares Nov 12 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 25,967 Shares Nov 08 2010 
Weekly CEO Buys Highlight: AOL Inc, Consolidated Graphics Inc, Saul Centers Inc, Hill-ROM Holdings, May 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) CEO John J Greisch buys 30,000 Shares May 12 2010 
HILL-ROM HOLDINGS, INC. Reports Operating Results (10-Q) Feb 04 2010 
HILL ROM HOLDINGS INC Reports Operating Results (10-Q) May 05 2009 

More From Other Websites
Hill-Rom to Participate in the Deutsche Bank 40th Annual Health Care Conference Apr 23 2015
Hill-Rom to Participate in the Deutsche Bank 40th Annual Health Care Conference Apr 23 2015
New Recommendations Guide Choice of Hospital Bed Surface to Prevent, Treat Pressure Ulcers Apr 08 2015
New Recommendations Guide Choice of Hospital Bed Surface to Prevent, Treat Pressure Ulcers Apr 08 2015
Hill-Rom Holdings, Inc. Hosts Fiscal 2015 Second Quarter Earnings Conference Call and Webcast Apr 07 2015
Hill-Rom Holdings, Inc. Hosts Fiscal 2015 Second Quarter Earnings Conference Call and Webcast Apr 07 2015
HILL-ROM HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Mar 06 2015
Hill-Rom Elects Stacy Enxing Seng to its Board of Directors Mar 04 2015
Hill-Rom Elects Stacy Enxing Seng to its Board of Directors Mar 04 2015
Hill-Rom Declares Second Quarter 2015 Dividend Mar 04 2015
Hill-Rom Declares Second Quarter 2015 Dividend Mar 04 2015
HILL-ROM HOLDINGS, INC. Financials Feb 07 2015
HILL-ROM HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 03 2015
Q1 2015 Hill-Rom Holdings Inc Earnings Release - Before Market Open Feb 03 2015
Hill-Rom misses 1Q profit forecasts Feb 03 2015
Hill-Rom misses 1Q profit forecasts Feb 03 2015
Hill-Rom Reports Fiscal First Quarter Results; Updates Fiscal 2015 Financial Outlook Feb 03 2015
Why Earnings Season Could Be Great for Hill-Rom Holdings (HRC) - Tale of the Tape Feb 02 2015
FMHR Final Trade: INTC, EL & HRC Jan 15 2015
After-hours buzz: BlackBerry, Adobe, JPM & more Jan 14 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK